| JXHL1400218 | BMS-791325片 | beclabuvir | Tablet | Chemical Drugs | Import Drug Application | 2014-07-02 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | Certificate Issued | 2016-01-22 | view |
| JYHB1900824 | 盐酸达拉他韦片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2019-07-03 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb (Singapore) Pte Ltd;Astrazeneca Pharmaceuticals Lp | Filed | 2019-07-12 | view |
| JYHZ0900173 | 注射用盐酸头孢吡肟 | cefepime hydrochloride | Lyophilized | Chemical Drugs | License Renew | 2009-05-27 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Srl | Certificate Issued | 2012-09-21 | view |
| B20020025 | 司坦夫定胶囊 | stavudine | Capsule | Chemical Drugs | Import Drug Application | 2002-04-22 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Approval Completed-Pending Certificated | 2002-09-09 | view |
| JYHF1700045 | 阿舒瑞韦软胶囊 | asunaprevir | Soft capsules | Chemical Drugs | Supplementary Application | 2017-05-15 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Catalent Pharma Solutions LLC;Bristol-Myers Squibb (Singapore) Pte Ltd | Certificate Issued | 2017-07-04 | view |
| JXHL1600077 | 盐酸达拉他韦 | daclatasvir dihydrochloride | Active ingredient | Chemical Drugs(5.1) | Import Drug Application | 2016-08-11 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Swords Laboratories | In Review | 2018-07-18 | view |
| JXSS1900069 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-12-26 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company | Certificate Issued | 2021-07-05 | view |
| JXHL1100254 | 丙氨酸布立尼布片 | brivanib alaninate | Tablet | Chemical Drugs | Import Drug Application | 2011-08-02 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | Certificate Issued | 2012-04-05 | view |
| JXHL1800066 | BMS-986205片 | BMS-986205 | Tablet | Chemical Drugs(1) | Import Drug Application | 2018-06-19 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | Certificate Issued | 2018-08-28 | view |
| JXHL0700060 | 阿哌沙班片 | apixaban | Tablet | Chemical Drugs(1.1) | Import Drug Application | 2007-03-19 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | Certificate Issued | 2007-11-12 | view |
| JXSL1700042 | Nivolumab注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2017-07-31 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Australia Pty Ltd | Certificate Issued | 2017-11-23 | view |
| JXHS1600062 | 盐酸达拉他韦片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2016-11-07 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Australia Pty Ltd;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2017-06-21 | view |
| JXSL2100005 | Relatlimab/Nivolumab固定剂量复方注射液 | nivolumab;relatlimab | Injection | Biological Products(1) | Import Drug Application | 2021-01-09 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | In Review | 2021-01-08 | view |
| JXSL1300030 | 伊匹木单抗注射液 | ipilimumab | Injection | Biological Products | Import Drug Application | 2013-04-28 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | Certificate Issued | 2015-07-27 | view |
| JXHL1900022 | BMS-986165 | deucravacitinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2019-02-02 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | In Review | 2019-02-01 | view |
| JYHB0701203 | 醋酸甲地孕酮口服混悬液 | megestrol acetate | Suspension | Chemical Drugs | Supplementary Application | 2007-12-19 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Contract Pharmaceuticals Ltd;Bristol-Myers Squibb Company | Certificate Issued | 2009-06-19 | view |
| H20020022 | 卡铂注射液 | carboplatin | Injection | Chemical Drugs | Import Drug Application | 2002-02-26 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Approval Completed-Pending Certificated | | view |
| JXSL1700001 | 伊匹木单抗注射液 | ipilimumab | Injection | Biological Products | Import Drug Application | 2017-01-22 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | Certificate Issued | 2017-05-25 | view |
| JXHL1600015 | 盐酸达拉他韦片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2016-02-16 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2016-10-31 | view |
| JYHB1901304 | 阿哌沙班片 | apixaban | Tablet | Chemical Drugs | Supplementary Application | 2019-11-09 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Manufacturing Company;Bristol-Myers Squibb / Pfizer Eeig | Certificate Issued | 2020-01-06 | view |
